News

Article

In the Lab eNewsletter

Pharmaceutical Technology's In the Lab eNewsletter 11-04-2020
Volume15
Issue 11

Samsung Biologics Incorporates Solentim’s Cell Line Development Technology into New R&D Center

Author(s):

Pharmaceutical Technology Editors

Samsung Biologics has adopted Solentim’s cell seeding and cell metric platforms at its new R&D center in San Francisco, CA.

Samsung Biologics has integrated Solentim’s VIPS single cell seeding platform and Cell Metric CLD platform to its R&D facility in San Francisco, CA. These instruments are designed for single-cell cloning and can ensure monoclonality to increase the speed and efficiency of master cell bank development.

With the additions, Samsung’s San Francisco R&D facility can offer rapid, high quality development services, including cell line development. Solentim’s VIPS and Cell Metric CLD instruments will be used in conjunction with Samsung Biologics’ recently launched proprietary cell line platform, S-CHOice, which Samsung Biologics debuted in September 2020. The VIPS and Cell Metric CLD platforms were added in October 2020.

“We’re pleased to extend our long-standing partnership with Samsung Biologics, which has previously purchased and enjoyed success with our equipment in its headquarter operations,” said Mark Truesdale, CEO of Solentim, in an Oct. 7, 2020 company press release.

Source: Solentim​

Articles in this issue
Restructuring Method Transfer Through Global Sites
Restructuring Method Transfer Through Global Sites
Bringing Six Sigma to Preclinical Pharma R&D
SRI International Receives $4.3 million from DARPA to Develop a Rapid Response Therapeutic Manufacturing System
CMIC and SUSMED to Collaborate on Providing Digital Therapeutics Development Services
Rigaku Corporation Showcases Analytical Devices at Lab Conference
Samsung Biologics Incorporates Solentim’s Cell Line Development Technology into New R&D Center
AbCellera and Kodiak Sciences Collaborate to Develop Antibody Therapeutics for Eye Disorders
Thermo Fisher Scientific Adds New Smart Connected Services to its TSX Series ULT Freezers
New EpiMOGRIFY Technology Platform Offers Development Support for Allogeneic Cell Therapies
Novel Single-Cell Whole Genome Amplification Technology Made Commercially Available at ASHG 2020

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Subscribe Now!
Related Videos
A global supply chain map, visualizing the complex network of transportation routes and distribution centers | Image Credit: © venusvi - stock.adobe.com
Shortcut from point A to point B | Image Credit: © Olivier Le Moal - stock.adobe.com
Behind the Headlines, Episode 21: Waters-BD Merger, Merck’s $10B Bet, and Biotech’s Investment Frontiers
Wooden blocks spelling TARIFFS are placed on a map of North America, specifically over the United States and Mexico | Image Credit: © Rokas - stock.adobe.com
Jason Waite, International Trade Expert, Alston & Bird
Simona Guidi, Associate Director, ProPharma
Tore Bergsteiner
Behind the Headlines, Episode 20: CAR-T Milestones, Abbvie and Eli Lilly M&A Moves, and More
Related Content
White House | Image Credit: © Zack Frank - stock.adobe.com
August 1st 2025

Trump Sends Letters to 17 Leading Pharma Companies Outlining Most-Favored-Nation Drug Pricing Protocol

Patrick Lavery
If action is not taken within 60 days, the White House said it would “deploy every tool in our arsenal” to improve drug pricing practices for American patients.
Drug Solutions Podcast: Growth and Advancements in Fill/Finish
August 1st 2025

Drug Solutions Podcast: Growth and Advancements in Fill/Finish

Felicity Thomas
In this episode, Hanns-Christian Mahler from ten23 Health chats about the advances in fill/finish.
Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - © Artur - stock.adobe.com
August 1st 2025

FDA Changes Opioid Pain Medication Labeling Requirements

Susan Haigney
The changes, required for safety labeling of all opioid drugs, will emphasize the risks with long-term use to combat misuse and addiction.
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
August 1st 2025

Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines

Feliza Mirasol
In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Resignation concept in a professional office setting | Image Credit: © Jane Kelly - stock.adobe.com
August 1st 2025

FDA Shake-Up: Vinay Prasad Exits Amid Tumult in Biologics Oversight

Christopher Cole
Prasad’s short FDA tenure brought stricter review standards for gene and COVID vaccines, sparking biotech concern and political backlash.
Silver Spring, MD, USA - June 25, 2022: Closeup of the FDA sign seen at its headquarters campus in Silver Spring, Maryland. FDA is a federal agency of the Department of Health and Human Services. | Image Credit: © Tada Images - stock.adobe.com
August 1st 2025

3 Reasons FDA Says Quality Investments Are Essential for Drug Manufacturers and Patients

Patrick Lavery
FDA’s latest whitepaper shows how scalable quality management investments in pharma reduce costs, improve reliability, and help prevent drug shortages.